You are here: Home » Current Affairs » Coronavirus » News
Business Standard

India approves AstraZeneca's Covid-19 vaccine for emergency use

It is the first Covid-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the United States

Topics
Coronavirus Vaccine | Coronavirus | AstraZeneca

Reuters 

Photo: Reuters
AstraZeneca Covid-19 vaccine. File Photo: Reuters

India has approved the COVID-19 vaccine developed by and Oxford University, paving the way for a huge immunisation campaign in the world’s second most populous country.

Information and Broadcasting Minister Prakash Javadekar told reporters on Saturday the vaccine had been approved on Friday, confirming what sources close to the matter had told Reuters.

It is the first COVID-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the United States.

Javadekar said at least three more vaccines were waiting in line to be approved.

“India is perhaps the only country where at least four vaccines are getting ready,” he said.

“One was approved yesterday for emergency use, Serum’s COVISHIELD.” he said, referring to the fact that the shot is being made locally by the Serum Institute of India (SII).

India has reported more than 10 million COVID-19 cases, though its rate of infection has come down significantly from a mid-September peak.

The country hopes to inoculate 300 million of its 1.35 billion people in the first six to eight months of 2021.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, January 02 2021. 16:12 IST
RECOMMENDED FOR YOU